摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5'-benzoyl-2',3'-di-O-acetyl-guanosine | 1024591-78-3

中文名称
——
中文别名
——
英文名称
5'-benzoyl-2',3'-di-O-acetyl-guanosine
英文别名
[(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2-amino-6-oxo-1H-purin-9-yl)oxolan-2-yl]methyl benzoate
5'-benzoyl-2',3'-di-O-acetyl-guanosine化学式
CAS
1024591-78-3
化学式
C21H21N5O8
mdl
——
分子量
471.426
InChiKey
WRUNEOPWXBVSPS-NVQRDWNXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    34
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    173
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • COMPOUND HAVING INHIBITORY ACTIVITY ON A RHO-GTPASE CELL PROTEIN, A PROCESS FOR OBTAINING THE SAME, PHARMACEUTICAL COMPOSITIONS COMPRISING THEREOF AND A METHOD FOR THE TREATMENT OF RHO-GTPASE CELL PROTEIN-MEDIATED CONDITION
    申请人:Alonso Daniel Fernando
    公开号:US20090324708A1
    公开(公告)日:2009-12-31
    The present invention relates to a compound having inhibitory activity on a Rho-GTPase cell protein, the compound having the formula I (Formula I) wherein A is selected from N and N—H, R 1 is selected from H and NHR 3 , R 2 is selected from NHR 4 , OR 4 , O and halogen, R 3 is selected from H and —COR 5 , R 4 is selected from H, a C 1 -C 6 alkyl and a substituted or unsubstituted phenyl, R 5 is selected from a C 1 -C 12 alkyl and a substituted or unsubstituted phenyl, R 6 is selected from H, —COR 5 , —CO 2 R 5 , —PR 7 R 8 and —PR 7 R 8 OPR 7 R 8 R 8 R 7 , R 7 is selected from O and S, R 8 is selected from H, OR 4 and OSATE (—OCH 2 CH 2 SCOR 5 ), and wherein each represents a single bond or a double bond, provided that when one of them is a double bond the other one is a single bond, and pharmaceutically acceptable salts and derivatives thereof. In particular, the compounds of the invention may be used as antitumor agents the action of which interfere with the signaling pathways normally involved in tumor development processes. The invention also relates to processes for obtaining of compounds having inhibitory activity of a Rho-GTPase cell protein, to the pharmaceutical compositions thereof and to the therapeutic methods comprising the use of said compounds and compositions.
查看更多